Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition

NCT00177398 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00177398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00177398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition
Lead sponsor
University of Pittsburgh
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
August 31, 2006
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperglycemia, type 2 diabetes